• Soft·Ox Solutions - New ways of eradicating infections and fighting antimicrobial resistance.
  • Patented and clinically proven.
What are you looking for?

Company Info

SoftOx is listed on the Merkur marked at Oslo Stock exchange

Important Company Notices and Stock Exchange News

SoftOx Solutions AS

share Price Overview

SoftOx Solutions AS (Oslo) is a medical technology company. With its patented technology, SoftOx will develop a portfolio of antimicrobial products to solve global health challenges with skin infections, both antibiotic resistant and chronic infections. The company develops its products in collaboration with leading research institutions in the Nordic region. The work is supported by the Research Council of Norway and the EU. The first product is planned to be launched in Europe in 2020.

SoftOx Solutions AS

Share Capital Development

SoftOx has raised a total of NOK 140 million of which NOK 50 million was raised before the IPO (Initial Public Offering) at an average price of NOK 13 per share. After the IPO, SoftOx have had the following placements:

  • 21.12.2018 - NOK 15 million Private Placement with the support from new and existing shareholders. The Private Placement consists of 680 000 new shares, each at a subscription price of NOK 22.
  • 12.12.2019 - SoftOx has completed the Private Placement raising gross proceeds of approximately NOK 75 million through issuance of 3,125,000 new shares (the "New Shares") at a price of NOK 24 per share. The Private Placement received support from both new and existing shareholders.

Originated May 8, 2012, last modified February 18, 2019

Articles of Association SoftOx Solutions AS